A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
for Locally Advanced Solid Tumor
6 locations incl. New Haven
Sponsor: Ipsen
Sex: All·Age: 18+
Code: NCT07213817·Phase 1, Phase 2·Recruiting